Humatica advises Capvis on their recent investment in Xovis

ndetails

Humatica AG was retained to advise Capvis on its majority investment stake in Xovis, the global leader in people flow measurement and analytics. With the support of Capvis, Xovis’ management will continue to focus on growth and plans to enter new markets and business segments.

Humatica provided organisational due diligence services for this transaction.

To view the Press Release: Humatica advises Capvis on their recent investment in Xovis

 

 

Related News

Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards
27 Jan, 2026 By Humatica

Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards

Humatica has once again been short-listed for Actum’s 2026 Value Creation Award in the People & Organisational Strategy category. This recognition reflects Humatica’s 23‑year commitment…

Read more arrowicon
Why a Fit-for-Purpose Operating Model is Now a Strategic Imperative
21 Jan, 2026 By Claudio Limacher

Why a Fit-for-Purpose Operating Model is Now a Strategic Imperative

In many organizations, strategy promises growth, efficiency, and innovation—but day-to-day execution tells a different story. Decisions drag. Silos persist. Accountability blurs. Leaders work harder without…

Read more arrowicon
Humatica is again finalist for prestigious Real Deals Award
16 Jan, 2026 By Humatica

Humatica is again finalist for prestigious Real Deals Award

Humatica is once again shortlisted for Real Deals’ prestigious Private Equity Awards 2026 in the “Value Creation Adviser of the Year” category. This recognition underscores…

Read more arrowicon